
Genexol PM 30mg Injection
Marketer
Lupin Ltd
Salt Composition
Paclitaxel (30mg)
Overview Genexol PM 30mg Injection
Oncaspar (30mg injection) is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your oncologist based on your specific condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only under medical supervision. Typical side effects include nausea, vomiting, and fatigue. Serious side effects, such as edema (hands/lips), alopecia, and weight increase, are possible. Concurrent medications may mitigate some side effects; however, report unusual bleeding/bruising, sore throat, mouth sores, or fever immediately. This medication can suppress blood cell production, increasing infection risk. Regular blood work, including liver function tests, is mandatory. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, including antibiotics. Numerous drug interactions are possible. Pregnancy and breastfeeding are contraindicated; reliable contraception is essential for both partners throughout the treatment period.
Uses of Genexol PM 30mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Genexol PM 30mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Genexol PM 30mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Genexol PM 30mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Genexol PM 30mg Injection works:
Genexol PM 30mg Injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This action inhibits cancer cell growth, leading to their eventual demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Genexol PM 30mg Injection is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Genexol PM 30mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use justified if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Genexol PM 30mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Genexol PM 30mg Injection might induce adverse reactions impacting driving capabilities. While continued driving between treatment cycles isn't inherently prohibited, the injection's alcohol content warrants caution regarding driving.
KidneySAFE IF PRESCRIBED
Genexol PM 30mg Injection poses no safety concerns for individuals with kidney conditions; no dosage modification is necessary. Nevertheless, consult your physician regarding any pre-existing kidney disease.
LiverCAUTION
Patients with liver impairment should use Genexol PM 30mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Genexol PM 30mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Genexol PM 30mg Injection :
NA
Facts to Know About Genexol PM 30mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane-Based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
